MedPath

Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine

Phase 4
Conditions
Spinal Anesthesia
Neonates
Interventions
Registration Number
NCT01075490
Lead Sponsor
University Hospital, Montpellier
Brief Summary

This prospective, double blinded study investigates spinal anesthesia with or without clonidine added to bupivacaine in newborns. This study is based on duration measurement of spinal anesthesia and cardio respiratory recording during 24h for apnea detection.

Detailed Description

Ex premies and term neonates are two subgroups investigated separately. The overall objective is to validate lengthening of spinal anesthesia in newborns in order to avoid "rescue" general anesthesia that occur in 20-40 % of patients with plain bupivacaine.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Newborns less than 60 weeks old post-conceptional, former premature or not
  • Newborns requiring inguinal hernia or lower limbs surgery,
  • infants needing no more critical care assistance
  • Informed consent of parents
Exclusion Criteria
  • Spinal malformation,
  • Coagulopathy,
  • critical hemodynamics,
  • uncontrolled neurologic or metabolic pathology.
  • infection at injection point.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
term neonate, bupivacaine, clonidineclonidine-
prematurely born, bupivacaine, placeboclonidine-
prematurely born, bupivacaine, clonidineclonidine-
term neonate, bupivacaine, placeboclonidine-
Primary Outcome Measures
NameTimeMethod
number of "rescue" general anesthesiaend of surgery
Secondary Outcome Measures
NameTimeMethod
apnea and desaturation occurrenceduring 24h
duration of spinal anesthesiaduring 24h

Trial Locations

Locations (1)

CHU de Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath